Genomic Valley

News:

Diagnosed prevalent cases of type 1 diabetes to reach 3.166 mn in 2033: GlobalData | GMC to launch skull-base surgery unit | Apollo Radiology International acquires UK-based InHealth Limited | Integrated diagnostics powered by genomics set to transform India’s healthcare landscape in the next 5-7 years | Mumbai scientist wins top prize for rapid mpox testing kit | Goan company invests $30mn in San Jose firm | Surya Eye Hospital launches Oculus Myopia Master, diagnostic tool to track, manage myopia progression in children | Molbio Diagnostics invests $30 million in OptraSCAN | Mindray's troponin I assay safely rules out heart attacks early: US researchers | India: On the Verge of Becoming the Diabetes Capital of the World | IIT Guwahati develops cost-effective photodetector to transform healthcare and renewable energy | Neuberg Diagnostics, SP Medifort Hospital, Trivandrum host educational CME on laboratory investigation advances | Ethical Considerations for single embryo transfer in IVF | IIT-BHU develops low-cost microchip for diagnosis of chronic kidney disease | How can PPPs ensure equitable access to advanced diagnostic facilities in both urban and rural areas? | MedGenome US appoints Dr Felix Olale as President, CEO & Jennifer Rose as Executive Vice President, CCO | MicrobioTx launches India’s first fingerprick-based gut microbiome test | Diagnostics firm Qiagen reports rise in third-quarter revenue | Health Rounds: Surgeons may need to rethink knee replacement methods | New blood tests could transform Alzheimer’s diagnostics: GlobalData | Assam CM inaugurates new MRI machine at Guwahati Medical College and Hospital | Medtronic lifts annual profit view on strong demand for medical devices | Air emergency in Delhi: Like pollution, face mask prices hit upper end | Boston Scientific launches multi-functional imaging system AVVIGO | Poly Medicure joins zero emission maritime buyers alliance | Lubrizol and Polyhose to set up medical tubes manufacturing unit in Chennai | Transforming Surgery: Yashoda Group partners with Medtronic for robotic-assisted systems | Alcon cuts 2024 forecasts, as slow US hits surgical unit | Philips India introduces Azurion to elevate interventional procedures across multiple specialties | HC seeks report on status of faulty dialysis machines | Medical devices industry welcomes government's Rs 500 cr scheme | Becton Dickinson beats quarterly estimates on strength in drug-delivery devices | Solventum raises annual profit forecast on strong surgical product sales | Mettler-Toledo beats quarterly profit estimates on strong demand for its lab instruments | Insulet raises annual revenue forecast on strong demand for insulin pumps | US FDA approves Johnson & Johnson's device for heart condition | Steris beats quarterly estimates on continued demand for medical procedures | Advanced Brain Device Offers new hope for parkinson’s patients in India | India’s first hand transplant recovery supported by 3D printing innovation | Germany's Fresenius raises 2024 forecast after Q3 beat

Genomic Valley

News:

Diagnosed prevalent cases of type 1 diabetes to reach 3.166 mn in 2033: GlobalData | GMC to launch skull-base surgery unit | Apollo Radiology International acquires UK-based InHealth Limited | Integrated diagnostics powered by genomics set to transform India’s healthcare landscape in the next 5-7 years | Mumbai scientist wins top prize for rapid mpox testing kit | Goan company invests $30mn in San Jose firm | Surya Eye Hospital launches Oculus Myopia Master, diagnostic tool to track, manage myopia progression in children | Molbio Diagnostics invests $30 million in OptraSCAN | Mindray's troponin I assay safely rules out heart attacks early: US researchers | India: On the Verge of Becoming the Diabetes Capital of the World | IIT Guwahati develops cost-effective photodetector to transform healthcare and renewable energy | Neuberg Diagnostics, SP Medifort Hospital, Trivandrum host educational CME on laboratory investigation advances | Ethical Considerations for single embryo transfer in IVF | IIT-BHU develops low-cost microchip for diagnosis of chronic kidney disease | How can PPPs ensure equitable access to advanced diagnostic facilities in both urban and rural areas? | MedGenome US appoints Dr Felix Olale as President, CEO & Jennifer Rose as Executive Vice President, CCO | MicrobioTx launches India’s first fingerprick-based gut microbiome test | Diagnostics firm Qiagen reports rise in third-quarter revenue | Health Rounds: Surgeons may need to rethink knee replacement methods | New blood tests could transform Alzheimer’s diagnostics: GlobalData | Assam CM inaugurates new MRI machine at Guwahati Medical College and Hospital | Medtronic lifts annual profit view on strong demand for medical devices | Air emergency in Delhi: Like pollution, face mask prices hit upper end | Boston Scientific launches multi-functional imaging system AVVIGO | Poly Medicure joins zero emission maritime buyers alliance | Lubrizol and Polyhose to set up medical tubes manufacturing unit in Chennai | Transforming Surgery: Yashoda Group partners with Medtronic for robotic-assisted systems | Alcon cuts 2024 forecasts, as slow US hits surgical unit | Philips India introduces Azurion to elevate interventional procedures across multiple specialties | HC seeks report on status of faulty dialysis machines | Medical devices industry welcomes government's Rs 500 cr scheme | Becton Dickinson beats quarterly estimates on strength in drug-delivery devices | Solventum raises annual profit forecast on strong surgical product sales | Mettler-Toledo beats quarterly profit estimates on strong demand for its lab instruments | Insulet raises annual revenue forecast on strong demand for insulin pumps | US FDA approves Johnson & Johnson's device for heart condition | Steris beats quarterly estimates on continued demand for medical procedures | Advanced Brain Device Offers new hope for parkinson’s patients in India | India’s first hand transplant recovery supported by 3D printing innovation | Germany's Fresenius raises 2024 forecast after Q3 beat

ABOUT US

Who we are

Taking Care of Your Tomorrow

Welcome to Genomic Valley Biotech Limited, where innovation meets expertise to revolutionize healthcare. With a dedicated team boasting over 10 years of experience in Next-Generation Sequencing (NGS), oncology, and Artificial Intelligence (AI), we are at the forefront of integrating advanced technologies into biotechnology and healthcare solutions. Our team comprises highly skilled professionals passionate about utilizing their extensive knowledge to drive forward the fields of oncology research and diagnostics. We are committed to implementing both novel and validated methods, ensuring the delivery of accurate and confident results in our pursuit of better healthcare outcomes.

Genomic Valley Biotech Limited

ABOUT US

Who we are

Taking Care of Your Tomorrow
Genomic Valley Biotech Limited

Welcome to Genomic Valley Biotech Limited, where innovation meets expertise to revolutionize healthcare. With a dedicated team boasting over 10 years of experience in Next-Generation Sequencing (NGS), oncology, and Artificial Intelligence (AI), we are at the forefront of integrating advanced technologies into biotechnology and healthcare solutions. Our team comprises highly skilled professionals passionate about utilizing their extensive knowledge to drive forward the fields of oncology research and diagnostics. We are committed to implementing both novel and validated methods, ensuring the delivery of accurate and confident results in our pursuit of better healthcare outcomes.

SERVICES

Empowering healthcare with NGS and AI

We offer advanced Diagnostic Services using Next-Generation Sequencing (NGS) and AI for precise genetic analysis and personalized oncology treatments. Our Research Services drive innovation in oncology through NGS and AI, enhancing diagnostic tools and therapeutic strategies.

Personalized Healthcare

Personalized healthcare at Genomic Valley Biotech Limited is centered on tailoring medical treatment to individual patients based on their unique genetic profiles.

Genetic Disease Predisposition

Our genetic disease predisposition services focus on identifying individuals' susceptibility to various hereditary conditions.

Community Health Support

Community health support at Genomic Valley Biotech Limited aims to improve public health outcomes through comprehensive genomic screening programs.

AI-Based Genome Healthcare

At Genomic Valley Biotech Limited , we are pioneering AI-based genome healthcare research to revolutionize the way genetic data is analyzed and interpreted.

Metagenomics and Healthcare

Our metagenomics research focuses on studying the collective genomes of microbial communities within the human body and their impact on health and disease.

Extramural Research Project

Our extramural research projects involve collaborating with external academic institutions, research organizations, and industry partners to advance genomic science.

SERVICES

Empowering healthcare with NGS and AI

We offer advanced Diagnostic Services using Next-Generation Sequencing (NGS) and AI for precise genetic analysis and personalized oncology treatments. Our Research Services drive innovation in oncology through NGS and AI, enhancing diagnostic tools and therapeutic strategies.

Personalized Healthcare

Personalized healthcare at Genomic Valley Biotech Limited is centered on tailoring medical treatment to individual patients based on their unique genetic profiles.

Genetic Disease Predisposition

Our genetic disease predisposition services focus on identifying individuals' susceptibility to various hereditary conditions.

Community Health Support

Community health support at Genomic Valley Biotech Limited aims to improve public health outcomes through comprehensive genomic screening programs.

AI-Based Genome Healthcare

At Genomic Valley Biotech Limited , we are pioneering AI-based genome healthcare research to revolutionize the way genetic data is analyzed and interpreted.

Metagenomics and Healthcare

Our metagenomics research focuses on studying the collective genomes of microbial communities within the human body and their impact on health and disease.

Extramural Research Project

Our extramural research projects involve collaborating with external academic institutions, research organizations, and industry partners to advance genomic science.

FAQ

Frequently Asked Questions

For any other questions, please feel free to contact us.

FAQ

Frequently Asked Questions

For any other questions, please feel free to contact us.

TESTIMONIALS

What our users say

Here's what our clients around the internet are saying about us.

Amit

@DrAmit

Genomic Valley Biotech Limited will be a trailblazer in integrating Next-Generation Sequencing and AI into healthcare. Their expertise and commitment to innovation will be evident in the precision and reliability of their diagnostic services. As a healthcare provider, I will trust their data and solutions to enhance patient outcomes and support informed decision-making.

Mohit

@DrMohit

Genomic Valley Biotech Limited will be transformative. Their advanced AI-based genome healthcare research will provide us with invaluable insights into genetic patterns, driving innovation in our personalized medicine approaches. Their dedication to excellence and cutting-edge technology will be truly commendable.

Shikha

@DrShikha

The personalized healthcare services at Genomic Valley Biotech Limited will revolutionize our approach to patient care. By tailoring treatments based on unique genetic profiles, they will ensure our patients receive the most effective therapies with minimal adverse effects. Their expertise in NGS and AI will be unmatched, making them an invaluable partner in our healthcare journey.

TESTIMONIALS

What our users say

Here's what our clients around the internet are saying about us.

Amit

@DrAmit

Genomic Valley Biotech Limited will be a trailblazer in integrating Next-Generation Sequencing and AI into healthcare. Their expertise and commitment to innovation will be evident in the precision and reliability of their diagnostic services. As a healthcare provider, I will trust their data and solutions to enhance patient outcomes and support informed decision-making.

Mohit

@DrMohit

Genomic Valley Biotech Limited will be transformative. Their advanced AI-based genome healthcare research will provide us with invaluable insights into genetic patterns, driving innovation in our personalized medicine approaches. Their dedication to excellence and cutting-edge technology will be truly commendable.

Shikha

@DrShikha

The personalized healthcare services at Genomic Valley Biotech Limited will revolutionize our approach to patient care. By tailoring treatments based on unique genetic profiles, they will ensure our patients receive the most effective therapies with minimal adverse effects. Their expertise in NGS and AI will be unmatched, making them an invaluable partner in our healthcare journey.

GALLERY

A glimpse into our company

GALLERY

A glimpse into our company

CONTACT

Get in touch with us

Send us a message

Fill the form to contact us

Message

CONTACT

Get in touch with us

Send us a message

Fill the form to contact us

Message

Genomic Valley Biotech Limited

4 KM Stone, Berri Chhara Road, P.O. Tanda Heri, Tehsil Bahadurgarh, District Jhajjar, HARYANA, INDIA - 124 507

Email: info@genomicvalley.in

Phone: +91 98113 41542